Why must patient-specific DUR messages be overridden month after month?
There are two ProDUR denial messages which may be overridden by the provider. The two messages are: Therapeutic Duplication and Drug-to-Drug Interaction. Both of these edits require that the provider review the patients drug utilization and confirm appropriate drug therapy. Since information and warnings concerning drugs change frequently, it was determined that these two edits should be evaluated each time they occur in order to ensure appropriate drug therapy.
